Global Antibody Testing Market Size Report Segmented by Test Type (Immunoassays, Lateral Flow Assays, Rapid Tests), Application (Infectious Diseases, Autoimmune Diseases, Oncology), End User (Hospitals, Diagnostic Labs) Forecast to 2030
The global antibody testing market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the rising prevalence of infectious and chronic diseases, increasing demand for diagnostic testing, and advancements in antibody-based technologies such as multiplex assays and automation systems. To learn more about the research report, download a sample report.
Report Overview
Antibody testing encompasses a variety of diagnostic methods that identify antibodies in the blood to detect past infections, immune responses to vaccines, and autoimmune conditions. The market's growth is supported by increasing healthcare expenditure, advancements in diagnostics, and heightened global awareness about preventive healthcare.
To learn more about this report, download the PDF brochure
Rising Demand for Early Diagnostics and Immune Response Monitoring Driving Market Growth
The growing prevalence of various infectious diseases and autoimmune disorders has underscored the importance of antibody testing. According to the World Health Organization (WHO), nearly 1.3 million deaths annually are caused by chronic infections, many of which could be mitigated with early and accurate diagnosis. Additionally, the rise of immune checkpoint inhibitors in oncology has led to an increased need for immune-monitoring solutions. Antibody testing offers unique advantages, such as: infectious disease surveillance: used widely during pandemics (e.g., COVID-19) for population-level surveillance and immunity studies; Vaccine Efficacy Analysis: Assessing immune responses to vaccines, such as for influenza, COVID-19, and HPV. Autoimmune Diagnostics: Detecting autoantibodies to diagnose conditions like rheumatoid arthritis and systemic lupus erythematosus. Growing investments in healthcare infrastructure and advancements in assay technologies are driving the adoption of antibody testing globally.
Technological Advancements Transforming Antibody Testing
The antibody testing market is evolving rapidly due to innovations that improve sensitivity, efficiency, and scalability. Key advancements include: Multiplex Assays: Capable of detecting multiple antibodies in a single test, saving time and resources; Point-of-Care Rapid Tests: Offering instant results for infectious diseases and urgent clinical needs; Automated Platforms: Enhancing throughput and precision in diagnostic laboratories; AI-Powered Diagnostics: Integrating artificial intelligence for predictive insights and pattern recognition in antibody response; CRISPR-Based Diagnostics: Enabling next-generation precision testing for complex diseases. These advancements make antibody testing a cornerstone of modern diagnostics, supporting both clinical and research applications.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
Key players in the antibody testing market, including Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, and Siemens Healthineers, are actively investing in R&D, strategic collaborations, and product innovations to strengthen their market positions.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 – 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | 6% |
| Market Drivers |
|
| Market Opportunities |
|
| Segment Scope | Assay Type, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Abcam, Agilent Technologies, Becton Dickinson, and Company, Merck KGaA, and Creative Diagnostics |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Antibody testing Market Segmentation
This report by Medi-Tech Insights provides the size of the global antibody testing market at the regional- and country-level from 2023 to 2030. The report further segments the market based on assay type, application, and end user.
Market Size & Forecast (2023-2030), By Assay Type, USD Billion
- Immunoassays
- Lateral Flow Assays
- Others
Market Size & Forecast (2023-2030), By Application, USD Billion
- Infectious Diseases
- Autoimmune Diseases
- Oncology
- Transfusion Medicine
- Others
Market Size & Forecast (2023-2030), By End User, USD Billion
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
Market Size & Forecast (2023-2030), By Region, USD Billion
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the antibody testing market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the antibody testing market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region holds the highest market share? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players in the market?
- What are the key strategies adopted by market players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Global Antibody Testing Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of diabetes
- Increasing awareness of diabetes and the importance of diagnostic testing
- Increasing adoption of digital health tools
- Advancements in CGMs and insulin delivery systems
- Restraints/Challenges
- Competition from alternative diagnostics
- High costs of advanced testing
- Opportunities
- Expanding telemedicine adoption
- Rising demand for wearable and smart devices
- Untapped emerging markets
- Market Trends
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Antibody Testing Market Size & Forecast (2023-2030), By Assay Type, USD Billion
- Introduction
- Immunoassays
- Lateral Flow Assays
- Others
- Antibody Testing Market Size & Forecast (2023-2030), By Application, USD Billion
- Introduction
- Infectious Diseases
- Autoimmune Diseases
- Oncology
- Transfusion Medicine
- Others
- Antibody Testing Market Size & Forecast (2023-2030), By End User, USD Billion
- Introduction
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
- Global Antibody Testing Market Size & Forecast (2023-2030), By Region, USD Billion
- Introduction
- North America Antibody Testing Market Size & Forecast (2023-2030), By Country, USD Billion
- US
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Canada
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- US
- Europe Antibody Testing Market Size & Forecast (2023-2030), By Country, USD Billion
- UK
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Germany
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- France
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Italy
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Spain
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Europe
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- UK
- Asia Pacific (APAC) Antibody Testing Market Size & Forecast (2023-2030), By Country, USD Billion
- China
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Japan
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- India
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Asia Pacific
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- China
- Latin America (LATAM) Antibody Testing Market Size & Forecast (2023-2030), USD Billion
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Middle East & Africa (MEA) Antibody Testing Market Size & Forecast (2023-2030), USD Billion
- Market Size & Forecast, By Assay Type (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Key Players Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Expansions
- Key Players and their Competitive Positioning
- Key Player Profiles*
(Business Overview, Financial Performance**, Services Offered, Recent Developments)
- Abbott Laboratories
- Roche Diagnostics
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Siemens Healthineers
- Abcam
- Agilent Technologies
- Becton, Dickinson, and Company
- Merck KGaA
- Creative Diagnostics
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Hospitals, Diagnostic Laboratories, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
